News Focus
News Focus
icon url

runncoach

05/22/19 6:43 PM

#10753 RE: XenaLives #10752

I mean the National MS Society paid for the study. How much 3rd party does one need? Some competitors waited years on hopes of a MTA that didn't pan out so I understand why they might be suspicious but Alkon just mentioned John Hopkins for MS in March.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834718/

Are the pfizer employees 3rd party?
https://www.frontiersin.org/articles/10.3389/fphar.2018.00625/full

Is Nemours Children's Hospital "3rd party" for fragile X?

Is the National cancer society "3rd party"?
https://www.biospace.com/article/releases/neurotrope-announces-cooperative-research-and-development-agreement-for-bryostatin-1-with-the-national-cancer-institute/

Investors are here for AD and will find out shortly the answer. The closer it gets the more I like the idea of hitting the market the way AXSM did by holding other indications until after 2B success although I will take any news I get whenever it comes.

https://ih.advfn.com/stock-market/NASDAQ/axsome-therapeutics-inc-AXSM/chart/real-time